,i #aaeth ,,congress #ast ,session ,h4 ,r4 #bcgf ,,in ,,the ,,house ,,of ,,representatives ,may #d1 #bjag,mr4 ,lance 7for himself1 ,mrs4 ,dingell1 ,mr4 ,burgess1 and ,mr4 ,gene ,green of ,texas7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to amend the ,federal ,food1 ,drug1 and ,cosmetic ,act to protect and strengthen the drug supply chain in the ,united ,states by closing several statutory gaps in the penalty provisions of such ,act that apply to drug diversion and counterfeiting4 #a4 ,short title ,this ,act may be cited as the ,drug ,diversion and ,counterfeit ,crackdown ,act of #bjag4 #b4 ,sense of ,congress ,it is the sense of the ,congress that-- 7#a7 there should not be differing penalties under the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cja et seq47 for illegally diverting drugs into the ,united ,states that arbitrarily turn on the location where the drugs were initially manufactured2 7#b7 such disparity should be addressed by providing the same penalties for diverting drugs made outside the ,united ,states and intended for a foreign market as the penalties that exist for diverting drugs made inside the ,united ,states and intended for a foreign market2 7#c7 there should not be unequal treatment of counterfeiting and diversion1 enabling criminal enterprises to exploit statutory loopholes and jeopardize patient and consumer safety without fear of significant penalties2 and 7#d7 such unequal treatment should be addressed by increasing the penalties for counterfeiting to match the penalties for diversion4 #c4 ,protecting and strengthening the drug supply chain 7a7 ,diverted drugs ,paragraph 7#a7 of section #hja7;d7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cha7;d77 is amended-- 7#a7 by striking 7d77#a7 ,except as and inserting 7d77#a77;,a7 ,except as2 and 7#b7 by adding at the end the following3 7,b7 ,except as authorized by the ,secretary in the case of a drug that appears on the drug shortage list in effect under section #ejf;,e1 no drug that would be subject to section #ejc7;b71 and which is manufactured outside the ,united ,states and intended by the manufacturer or labeled to be marketed outside the ,united ,states1 may be imported into the ,united ,states for sale or commercial use4 4 7b7 ,counterfeit drugs ,subsection 7b7 of section #cjc of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #ccc7 is amended by adding at the end the following3 7#h7 ,notwithstanding subsection 7a71 any person who violates section #cja7;i77#c7 by knowingly selling or dispensing1 or holding for sale or dispensing1 a counterfeit drug shall be imprisoned for not more than #aj years or fined in accordance with title #ah1 ,united ,states ,code1 or both4 4